Fayoum University Report issue

Academic/Hospital Phase 1 Phase 2 Phase 3 Phase 4
Founded: Fayoum Egypt (2005)

Organization Overview

First Clinical Trial
2017
NCT03963336
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2023

Timeline

NOW
  • Now

Alternative names

Associated professor of obestatrics and gynecology Faculty of medicine Fayoume university | Department of Internal Medicine, Faculty of Medicine, Fayoum University, Fayoum, Egypt | Eygpt fayoum university | faculty of medicine -fayoum university | faculty of medicine , fayoum university | Faculty of medicine, Fayoum university | faculty of medicine ,Fayum university | Fayoum University | Fayoum university hodpital | Fayoum universty hospital | Shimaa M. Abdelgawad

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Headache (Phase 4)

Hypertension (Phase 1)

Intracranial Hypertension (Phase 1)

Pain, Postoperative (Phase 4)

Post-Dural Puncture Headache (Phase 4)

Pseudotumor Cerebri (Phase 1)

Strabismus (Phase 4)

Tooth, Impacted (Phase 3)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 28
  • # of Trial APIs: 30